Every SEC Form 3/4/5 on record for this filer (CIK 1298711) — 2 issuers, 261 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | President, R&D · Director | 2017-09-19 → 2026-06-05 | 39 | −$125M |
| XON | INTREXON CORP | SVP--Product Development · lapsed | 2015-12-04 → 2016-02-01 | 2 | −$745,308 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KRYS | 2026-06-04 | Sell | 1,348 | $307.09 | $413,957 | 1,399,767 |
| KRYS | 2026-06-04 | Sell | 2,039 | $310.94 | $634,007 | 1,378,395 |
| KRYS | 2026-06-04 | Sell | 2,801 | $309.95 | $868,170 | 1,380,434 |
| KRYS | 2026-06-04 | Sell | 3,803 | $308.89 | $1M | 1,383,235 |
| KRYS | 2026-06-04 | Sell | 12,729 | $307.81 | $4M | 1,387,038 |
| KRYS | 2026-06-04 | Sell | 240 | $311.65 | $74,796 | 1,378,155 |
| KRYS | 2026-06-04 | Sell | 480 | $305.87 | $146,818 | 1,401,115 |
| KRYS | 2026-06-04 | Sell | 400 | $304.89 | $121,956 | 1,401,595 |
| KRYS | 2026-06-04 | Sell | 247 | $303.17 | $74,883 | 1,401,995 |
| KRYS | 2026-06-04 | Sell | 593 | $302.25 | $179,234 | 1,402,242 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.